About Cangen
Cangen was founded in 2015 and is based in the United Kingdom. Special-purpose machinery is produced by the company within the manufacturing sector. Operations focus on the design and fabrication of customized equipment tailored to specific industrial requirements. Services include machinery development for various applications, with the companys online presence maintained at cangen.co.uk. Activities are conducted primarily in the UK market.
- Headquarter United Kingdom
-
Sectors
Industrial Goods & Manufacturing
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cangen
Detailed funding history for Cangen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cangen
Cangen has secured backing from 1 investor. Prominent investors backing the company include Milacron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Plastic processing equipment manufacturer
|
Locked | Locked | Locked |
Investor details for Cangen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cangen
Investment portfolio details for Cangen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cangen
Detailed financials for Cangen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cangen Comparisons
Peer comparison for Cangen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cangen
Detailed competitors of Cangen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cangen
Complete news archive for Cangen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cangen
Cangen was founded in 2015.
Cangen is headquartered in United Kingdom.
Cangen was founded in 2015 and is based in the United Kingdom. Special-purpose machinery is produced by the company within the manufacturing sector. Operations focus on the design and fabrication of customized equipment tailored to specific industrial requirements. Services include machinery development for various applications, with the companys online presence maintained at cangen.co.uk. Activities are conducted primarily in the UK market.
Cangen has 1 investor. Key investors include Milacron.